20/20 Biolabs (AIDX) Revenue & Revenue Breakdown
20/20 Biolabs Revenue Highlights
Latest Revenue (Y)
$2.05M
Latest Revenue (Q)
$730.57K
20/20 Biolabs Revenue by Period
20/20 Biolabs Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $2.05M | 16.71% |
| 2024-12-31 | $1.75M | 23.03% |
| 2023-12-31 | $1.42M | -87.12% |
| 2022-12-31 | $11.06M | 14.93% |
| 2021-12-31 | $9.62M | 312.88% |
| 2020-12-31 | $2.33M | 708.37% |
| 2019-12-31 | $288.30K | 4.06% |
| 2018-12-31 | $277.05K | -11.55% |
| 2017-12-31 | $313.21K | -26.65% |
| 2016-12-31 | $427.00K | -21.56% |
| 2015-12-31 | $544.38K | - |
20/20 Biolabs generated $2.05M in revenue during NA 2025, up 16.71% compared to the previous quarter, and up 87.75% compared to the same period a year ago.
20/20 Biolabs Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $730.57K | 106.74% |
| 2026-03-31 | $353.38K | -34.35% |
| 2025-12-31 | $538.27K | 28.78% |
| 2025-09-30 | $417.98K | -21.88% |
| 2025-06-30 | $535.06K | -3.39% |
| 2025-03-31 | $553.82K | 3.31% |
| 2024-12-31 | $536.08K | 48.50% |
| 2024-09-30 | $361.01K | -15.58% |
| 2024-06-30 | $427.63K | - |
| 2024-03-31 | $427.63K | 27.84% |
| 2023-12-31 | $334.49K | 0.00% |
| 2023-09-30 | $334.49K | -0.43% |
| 2023-06-30 | $335.94K | -19.90% |
| 2023-03-31 | $419.38K | -57.37% |
| 2022-12-31 | $983.76K | - |
| 2022-09-30 | $983.76K | -76.18% |
| 2022-06-30 | $4.13M | -16.78% |
| 2022-03-31 | $4.96M | 27.05% |
| 2021-12-31 | $3.91M | - |
| 2021-09-30 | $3.91M | 331.39% |
| 2021-06-30 | $905.39K | -0.00% |
| 2021-03-31 | $905.40K | 16.95% |
| 2020-06-30 | $774.18K | - |
| 2020-03-31 | $774.18K | 1004.78% |
| 2019-06-30 | $70.08K | - |
| 2019-03-31 | $70.08K | -7.42% |
| 2018-12-31 | $75.69K | - |
| 2018-09-30 | $75.69K | 20.47% |
| 2018-06-30 | $62.83K | - |
| 2018-03-31 | $62.83K | -30.75% |
| 2017-12-31 | $90.73K | - |
| 2017-09-30 | $90.73K | 37.73% |
| 2017-06-30 | $65.88K | - |
| 2017-03-31 | $65.88K | -31.58% |
| 2016-12-31 | $96.28K | - |
| 2016-09-30 | $96.28K | 0.75% |
| 2016-06-30 | $95.57K | -0.00% |
| 2016-03-31 | $95.57K | - |
20/20 Biolabs generated $730.57K in revenue during Q2 2026, up 106.74% compared to the previous quarter, and up 131.91% compared to the same period a year ago.